Orion (NYSE:OEC) Price Target Cut to $10.00 by Analysts at Mizuho

Orion (NYSE:OEC - Get Free Report) had its price target decreased by analysts at Mizuho from $12.00 to $10.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a "neutral" rating on the specialty chemicals company's stock. Mizuho's price objective would indicate a potential downside of 6.06% from the company's previous close.

Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. lowered Orion from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $18.00 to $12.00 in a research note on Thursday, April 24th. UBS Group dropped their price target on Orion from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Thursday, May 8th.

Orion Price Performance

Shares of NYSE:OEC traded up $0.03 during trading on Tuesday, hitting $10.65. 255,558 shares of the company's stock were exchanged, compared to its average volume of 573,548. The company has a debt-to-equity ratio of 1.41, a current ratio of 1.14 and a quick ratio of 0.65. Orion has a 52-week low of $9.59 and a 52-week high of $24.85. The business's 50-day simple moving average is $10.92 and its 200 day simple moving average is $12.62. The company has a market cap of $598.99 million, a price-to-earnings ratio of 23.24 and a beta of 1.07.

Orion (NYSE:OEC - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The specialty chemicals company reported $0.22 EPS for the quarter, missing analysts' consensus estimates of $0.53 by ($0.31). Orion had a net margin of 1.44% and a return on equity of 17.66%. The firm had revenue of $477.70 million for the quarter, compared to the consensus estimate of $486.06 million. During the same period in the previous year, the company posted $0.52 earnings per share. Orion's quarterly revenue was down 5.0% on a year-over-year basis. As a group, equities analysts predict that Orion will post 1.73 EPS for the current year.

Institutional Investors Weigh In On Orion

Several institutional investors have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Orion by 3.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,857 shares of the specialty chemicals company's stock valued at $438,000 after purchasing an additional 1,097 shares during the last quarter. Inspire Investing LLC lifted its stake in shares of Orion by 4.9% in the 1st quarter. Inspire Investing LLC now owns 26,584 shares of the specialty chemicals company's stock valued at $344,000 after purchasing an additional 1,233 shares during the last quarter. MetLife Investment Management LLC lifted its stake in shares of Orion by 5.9% during the 4th quarter. MetLife Investment Management LLC now owns 35,294 shares of the specialty chemicals company's stock worth $557,000 after acquiring an additional 1,954 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Orion by 30.3% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 13,108 shares of the specialty chemicals company's stock worth $169,000 after acquiring an additional 3,046 shares during the last quarter. Finally, Heartland Advisors Inc. lifted its stake in shares of Orion by 0.8% during the 1st quarter. Heartland Advisors Inc. now owns 450,000 shares of the specialty chemicals company's stock worth $5,818,000 after acquiring an additional 3,450 shares during the last quarter. 94.33% of the stock is owned by institutional investors.

Orion Company Profile

Orion SA, together with its subsidiaries, engages in the manufacture and sale of carbon black products. It operates in two segments, Specialty Carbon Black and Rubber Carbon Black. The company offers post-treated specialty carbon black grades for coatings and printing applications; high purity carbon black grades for the fiber industry; and conductive carbon black grades for batteries, polymers, and coatings.